Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

BCLIBCLI
4 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in BrainStorm Cell Therapeutics In

GEODE CAPITAL MANAGEMENT, LLC previously held 0 shares of BCLI (BrainStorm Cell Therapeutics In), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$119,206

Total Shares Change

-52,501

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$0.70
0
2025-Q2
Decreased
54,582
-6.2%
$61,1430.0%$1.06
0
2025-Q1
Increased
58,165
+10.8%
$73,3030.0%$1.19
16
2024-Q4
New
52,501
-
$119,2060.0%$2.37
34

Other major holders of BCLI: VANGUARD GROUP INC, BlackRock, Inc., HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used